Serious Incident Reporting: Vigilance, Field Safety Corrective Action and Reporting Deadlines

SUMMARY
Serious incident reporting is the manufacturer’s reporting to the Authority and the other competent authorities of serious incidents involving a device made available on the market. Its basis is Article 85 of the Medical Device Regulation (Tıbbi Cihaz Yönetmeliği); the deadlines are 15, 10 and 2 days.
In this article we give the definitions, the scope of reporting, the deadlines, the field safety corrective action, the investigation and final report, and the onward-reporting obligations in the supply chain, quoting the text of the regulation word for word.
For the ÜTS registration and individual notifications of your devices: Medical Device ÜTS Registration Consultancy
Table of Contents
1. Definitions: Adverse Event, Serious Incident and Field Safety
Article 3 of the Medical Device Regulation (Tıbbi Cihaz Yönetmeliği):
“nn) Adverse event: Any malfunction or deterioration in the characteristics or performance of a device made available on the market, including use-errors due to ergonomic features, as well as any inadequacy in the information supplied by the manufacturer and any undesirable side-effect,”
“ı) Serious incident;”
“1) the death of a patient, user or other person,”
“2) the temporary or permanent serious deterioration of a patient’s, user’s or other person’s state of health,”
“3) a serious public health threat,”
“any adverse event that directly or indirectly led, might have led or might lead to any of the following,”
“h) Serious public health threat: Any event which could result in imminent risk of death, serious deterioration in a person’s state of health, or serious illness, that may require prompt remedial action, and that may cause significant morbidity or mortality in humans, or that is unusual or unexpected for the given place and time,”
The definition of a serious incident covers not only an outcome that has occurred but also events that “might have led or might lead” to one. For the concepts, see our page what is a serious incident.
Two definitions on field safety:
“zz) Field safety corrective action: Corrective action taken by the manufacturer for technical or medical reasons to prevent or reduce the risk of a serious incident in relation to a device made available on the market,”
“yy) Field safety notice: A communication sent by the manufacturer to users or customers in relation to a field safety corrective action,”
For details, see our page what is a field safety corrective action.
2. What Is Reported? Article 85, Paragraph 1
“(1) Except for investigational devices, manufacturers of devices made available on the market shall report to the Authority and the other relevant competent authorities, in accordance with the fourth and sixth paragraphs of Article 89, the following. These reports shall be submitted through the electronic system referred to in Article 89:”
“a) Any serious incident involving devices made available on the market is reported (the “expected side-effects” that are clearly documented in the product information, quantified in the technical documentation and subject to trend reporting under Article 86 are excluded from this reporting).”
“b) Any field safety corrective action in respect of devices made available lawfully on the market in Türkiye or in EU member states, including field safety corrective actions undertaken in countries outside these, is reported (the case where the reason for the field safety corrective action is limited to a device on the market of countries outside Türkiye and the European Union is excluded from this reporting).”
The exception in sub-paragraph (a) lists three conditions that must be met together: the side-effect is clearly documented in the product information, its quantity is stated in the technical documentation, and it is subject to trend reporting under Article 86. For the full text of the article, see our page serious incident reporting: Article 85.
3. Reporting Deadlines: 15, 10 and 2 Days
“(2) As a general rule, the severity of the serious incident shall be taken into account in the deadlines for the reports referred to in the first paragraph.”
“(3) Manufacturers shall report any serious incident as referred to in sub-paragraph (a) of the first paragraph immediately after they have established the causal relationship between that incident and their device or that such causal relationship is reasonably possible. This period shall not exceed 15 days after the manufacturers become aware of the adverse event.”
“(4) Notwithstanding the third paragraph, in the event of a serious public health threat the report referred to in the first paragraph shall be submitted immediately, and this period shall not exceed 2 days after the manufacturer becomes aware of the threat.”
“(5) Notwithstanding the third paragraph, in the event of death or an unanticipated serious deterioration in a person’s state of health, the report shall be submitted immediately after the manufacturer has established or suspected a causal relationship between the device and the serious incident, and this period shall not exceed 10 days after the manufacturer becomes aware of the serious incident.”
Serious incident: immediately, and no later than 15 days (85/3).
Death or unanticipated serious deterioration in a person’s state of health: immediately, and no later than 10 days (85/5).
Serious public health threat: immediately, and no later than 2 days (85/4).
All three periods start when the manufacturer becomes aware of the incident or the threat.
4. Initial Report and Cases Where the Manufacturer Is Not Sure
“(6) Where necessary to ensure timely reporting, the manufacturer may submit an initial report followed by a complete report.”
“(7) After becoming aware of a potentially reportable adverse event, the manufacturer shall submit a report within the time frame required under the second to fifth paragraphs, even if it is not sure whether the adverse event is reportable.”
Under the seventh paragraph, doubt as to whether the event is reportable does not change the reporting period.
5. When Is a Field Safety Corrective Action Reported?
“(8) Except in urgent cases where the manufacturer must take a field safety corrective action immediately, the manufacturer shall report the field safety corrective action referred to in sub-paragraph (b) of the first paragraph without delay, before taking that action.”
The content of the field safety notice is set out in the eighth paragraph of Article 87:
“a) The manufacturer shall ensure that information about the field safety corrective action is brought without delay to the attention of the users of the device concerned by means of a field safety notice. The field safety notice shall be drawn up in Turkish and/or in the official EU language(s) determined by the EU member states in which the field safety corrective action is taken. Except in urgent cases, the content of the draft field safety notice shall be submitted to the Authority, or in the cases referred to in the ninth paragraph to the coordinating competent authority, to allow it to make comments.”
“b) The field safety notice shall allow the correct identification of the device or devices concerned, in particular by including the relevant UDIs, and the correct identification of the manufacturer that carried out the field safety corrective action, in particular by including the single registration number if it has already been issued. The field safety notice shall explain, in a clear manner and without understating the level of risk, the reasons for the field safety corrective action with reference to the device malfunction and the associated risks to patients, users or other persons, and shall clearly indicate all actions to be taken by users.”
“c) The manufacturer shall enter the field safety notice into the electronic system referred to in Article 89, through which it shall be made accessible to the public.”
Under the fifth paragraph of Article 27 of the Regulation, the UDI is used for reporting serious incidents and field safety corrective actions under Article 85. For recall and withdrawal notifications in ÜTS, see our article on market surveillance and recall.
6. Periodic Summary Report and Trend Reporting
Under the ninth paragraph of Article 85, for similar serious incidents occurring with the same device or device type, the manufacturer may submit a periodic summary report instead of individual reports where:
“a) the root cause has been identified,”
“b) a field safety corrective action has been implemented,”
“c) the adverse events are common and well documented,”
The condition for this is that the coordinating competent authority, in consultation with the Authority and the other competent authorities, agrees with the manufacturer on the format, content and frequency of the periodic summary reporting.
Any statistically significant increase in the frequency or severity of adverse events that are not serious incidents, or that are expected undesirable side-effects, is reported by a trend report under Article 86. Under Article 86, the manufacturer states in the post-market surveillance plan how it will manage these events, the methodology used and the observation period. For the plan, see our article on post-market surveillance and PSUR.
7. Investigation and Final Report: Article 87
“(1) Following the reporting of a serious incident pursuant to the first paragraph of Article 85, the manufacturer shall without delay perform the necessary investigations in relation to the serious incident and the devices concerned.”
“The manufacturer shall also not perform any investigation which involves altering the device or a sample of the batch concerned in a way which may affect any subsequent evaluation of the causes of the incident, prior to informing the Authority and the other competent authorities of such action.”
“(5) The manufacturer shall submit a final report setting out its findings from the investigation to the relevant competent authority through the electronic system referred to in Article 89. The report shall set out conclusions and, where relevant, indicate corrective actions to be taken.”
Under the fourth paragraph of the same article, the Authority monitors the manufacturer’s investigation and, where necessary, may intervene in it or initiate an independent investigation.
8. Healthcare Professionals, Importers, Distributors and Sales Centers
“(10) Suspected serious incidents referred to in sub-paragraph (a) of the first paragraph shall be reported to the Authority by healthcare professionals, users and patients. The Authority shall record these reports centrally.”
Under the eleventh paragraph of Article 85, the Authority ensures that the manufacturer is informed without delay of these reports. If the manufacturer does not consider the event to be serious or considers it an expected undesirable side-effect, it submits an explanatory statement; if the Authority does not agree with this assessment, it may require a report to be submitted.
Onward-reporting obligations in the supply chain:
Importer (Art. 13/8): promptly forwards complaints and reports about suspected adverse events to the manufacturer and the authorised representative.
Distributor (Art. 14/5): promptly forwards this information to the manufacturer and, if any, to the authorised representative and the importer.
Authorised representative (Art. 11): promptly informs the manufacturer about complaints and reports concerning the device for which it is appointed.
Manufacturer (Art. 10/13): has a system in place for recording and reporting adverse events and field safety corrective actions.
Under Article 31 of the Medical Device Sales, Advertising and Promotion Regulation (Tıbbi Cihaz Satış, Reklam ve Tanıtım Yönetmeliği), sales centers immediately notify the Authority and the manufacturer or importer of the device concerned of the adverse events they encounter; the ninth paragraph of Article 10 places the same obligation on the responsible manager. For the obligations of importers and distributors, see our article on importer and distributor obligations.
According to the ÜTS User and Company Transactions Help Guide (Question A1-6), the “Medical Device Vigilance Officer” (“Tıbbi Cihaz Vijilans Sorumlusu”) is one of the senior user roles in ÜTS.
9. Electronic System and Transition: EUDAMED Vigilance Module
The reports under Article 85 are submitted through the electronic system in Article 89 (EUDAMED). Under sub-paragraph (a) of the first paragraph of Article 111 of the Regulation, Articles 85 and 86 apply 6 months after the date on which the notice that the Commission has confirmed the relevant electronic system to be functional is published in the Official Journal of the European Union. Until that date, Provisional Article 1 applies:
“(12) (Amended: RG-17/8/2024-32635)(4) The relevant provisions of the Medical Device Regulation and the Active Implantable Medical Devices Regulation repealed by Article 110, concerning vigilance reporting, clinical investigations, registration of devices and economic operators and certificate notifications, continue to apply until the date of application of the provisions referred to in sub-paragraph (a) of the first paragraph of Article 111.”
Questions and Answers document on the phased implementation of EUDAMED, published in Turkish by TİTCK in November 2024 (Q13):
“The VGL (vigilance) module is not available for voluntary use. It will be made available when it becomes mandatory, and from that moment its use will be mandatory.”
For the EUDAMED modules, see our article on EUDAMED registration.
10. Frequently Asked Questions
How many days do I have to report a serious incident?
Under the third paragraph of Article 85, immediately, and no later than 15 days after the manufacturer becomes aware of the incident. In the case of death or an unanticipated serious deterioration it is no later than 10 days, and for a serious public health threat no later than 2 days.
What do we do if we are not sure the event is reportable?
Under the seventh paragraph of Article 85, the manufacturer submits a report within the periods in the second to fifth paragraphs even if it is not sure. Under the sixth paragraph, an initial report may be submitted before the full report.
Is a field safety corrective action reported before it is implemented?
Yes. Under the eighth paragraph of Article 85, except in urgent cases that require immediate action, it is reported without delay before the action is carried out.
In which language is the field safety notice prepared?
Under sub-paragraph (a) of the eighth paragraph of Article 87, it is drawn up in Turkish and/or in the official EU language(s) determined by the EU member states in which the action is carried out.
Can a returned device be examined immediately?
Under the first paragraph of Article 87, an investigation that alters the device or a sample of the batch in a way that may affect any subsequent evaluation of the causes of the event is not carried out without informing the Authority and the other competent authorities.
For the ÜTS registration and individual notifications of your devices: Medical Device ÜTS Registration Consultancy
Sources



